Samjo Management LLC Acquires New Stake in Certara, Inc. (NASDAQ:CERT)

Samjo Management LLC bought a new position in shares of Certara, Inc. (NASDAQ:CERT) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 190,000 shares of the company’s stock, valued at approximately $2,024,000.

A number of other large investors have also modified their holdings of the business. Charles Schwab Investment Management Inc. grew its holdings in Certara by 1.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 699,575 shares of the company’s stock valued at $8,192,000 after buying an additional 12,720 shares in the last quarter. State Street Corp increased its position in Certara by 3.4% during the third quarter. State Street Corp now owns 3,679,699 shares of the company’s stock worth $43,089,000 after purchasing an additional 122,411 shares during the last quarter. Jane Street Group LLC raised its stake in Certara by 2.6% during the third quarter. Jane Street Group LLC now owns 147,393 shares of the company’s stock worth $1,726,000 after purchasing an additional 3,732 shares during the period. Barclays PLC boosted its holdings in Certara by 198.3% in the 3rd quarter. Barclays PLC now owns 70,525 shares of the company’s stock valued at $825,000 after purchasing an additional 46,880 shares during the last quarter. Finally, 272 Capital LP purchased a new stake in shares of Certara in the 3rd quarter valued at approximately $586,000. Hedge funds and other institutional investors own 73.96% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently commented on CERT shares. Barclays lifted their price target on shares of Certara from $12.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. TD Cowen started coverage on shares of Certara in a report on Thursday, February 27th. They issued a “buy” rating and a $16.00 price objective on the stock. Stephens reiterated an “overweight” rating and issued a $17.00 target price on shares of Certara in a report on Thursday, February 27th. Finally, William Blair restated a “market perform” rating on shares of Certara in a research report on Thursday, February 27th. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, Certara currently has an average rating of “Moderate Buy” and an average target price of $15.83.

Certara Trading Down 2.4 %

CERT opened at $9.55 on Friday. The business has a fifty day moving average price of $12.14 and a 200 day moving average price of $11.41. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86. Certara, Inc. has a 12 month low of $9.21 and a 12 month high of $19.18. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of -47.75, a PEG ratio of 9.29 and a beta of 1.64.

Certara Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.